Evaluation of the Safety and Performance of ESTYME® MATRIX Round and Anatomical Breast Implants

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-03-23

Study Completion Date

2021-04-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study will evaluate the safety and performance of the ESTYME® MATRIX Round and Anatomical Silicone Gel-Filled Breast Implants in the breast augmentation and reconstruction.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of the Safety and Performance of SYMATESE AESTHETICS ESTYME® MATRIX Round Microtextured Silicone Gel-Filled Breast Implants in the Breast Augmentation

NCT05336526

Bilateral Breast Augmentation

ACTIVE_NOT_RECRUITING NA

Adjunct Study of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants

NCT00691327

Breast Reconstruction

COMPLETED NA

An Analysis of Adverse Events and Satisfaction Outcomes of Women Who Underwent Primary and Secondary Breast Augmentation Using Silimed® Breast Implants

NCT03356132

Breast Implant; Complications Quality of Life Satisfaction

RECRUITING

Post-market Prospective Clinical Study of Nagor Perle Mammary Implants

NCT06013514

Breast Reconstruction Breast Reconstruction Following Mastectomy Breast Revision +5 more

RECRUITING

Core Gel Study of the Safety and Effectiveness of Mentor Round Low Bleed Silicone Gel-filled Mammary Prostheses

NCT00753922

Breast Reconstruction Breast Augmentation Breast Revision

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will evaluate the safety and performance of the ESTYME® MATRIX Round and Anatomical Silicone Gel-Filled Breast Implants in the breast augmentation and reconstruction at 3 months, 1 year and 2 years post-procedure

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Augmentation Breast Reconstruction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ESTYME MATRIX

Participants who meet the requirements for breast augmentation or breast reconstruction surgeries and have been implanted with one or two ESTYME® MATRIX Breast Implant(s)

Group Type EXPERIMENTAL

ESTYME® MATRIX Breast Implants

Intervention Type DEVICE

Breast implant surgery in breast reconstruction or breast augmentation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ESTYME® MATRIX Breast Implants

Breast implant surgery in breast reconstruction or breast augmentation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patient will be included if all of the following criteria are met:

1. Subject of between 18 and 65 years old
2. Candidate eligible for :

a. unilateral or bilateral breast augmentation i. general breast enlargement: cosmetic purposes, providing symmetry to opposite breast in case of unilateral surgery ii. surgical correction of various congenital or acquired anomalies such as amastia, aplasia, hypomastia, hypoplasia, asymmetries, Poland's syndrome, ptosis …

b. or immediate or delayed unilateral or bilateral breast reconstruction (for cancer, trauma, surgical loss of breast)
3. Patient signs PIC (Patient Informed Consent) \& willing to comply with the protocol assessments and visits follow up

Exclusion Criteria

Patient will not be included if any of the following conditions exists:

1. Local or systemic infection or abscess anywhere in the body
2. Existing carcinoma or pre-carcinoma of the breast without treatment or mastectomy treatment without appropriate wash out period for chemotherapy at the surgeon discretion
3. Subject with previous tissue expansion
4. Diagnosis of active cancer of any type for augmentation procedure subject
5. Pregnant subject or intending to become pregnant within three (3) months of the implant procedure
6. Subject who had nursed within three (3) months of implant surgery, or still breastfeeding
7. Tissue characteristics determined clinically inadequate or unsuitable by the surgeon (i.e. tissue damage resulting from radiation, inadequate tissue or compromised vascularity, know complication wound healing)
8. Previously implanted subject with a silicone implant or History of failure following cosmetic augmentation or subcutaneous mastectomy
9. History of autoimmune disease such as but not limited to: lupus, scleroderma …
10. Any condition or treatment for any condition which, in the opinion of the physician, may constitute an unwarranted surgical risk (e.g. anaesthesia allergy, high consumption smoking subject …)
11. Anatomic or physiologic abnormality which could result to significant post-operative complications
12. History of sensitivity of foreign materials or known allergy to any component of the ESTYME® MATRIX Silicone Gel-Filled Breast Implant
13. Subject known for alcohol abuse/history
14. Underlying disease (HIV positive Subject, HF (heart Failure), renal insufficiency, diabetes, hypertension, …)
15. Subject with implanted metal or metal devices, history of claustrophobia, or other condition that would make a MRI scan prohibitive
16. Unwilling to undergo any further surgery for revision
17. Subject with willingness that are unrealistic/unreasonable with the risks involved with the surgical procedure
18. Participating into any other clinical study or had participated into a clinical study without appropriate wash out period at the surgeon discretion
19. Subject who has sociological, cultural or geographical factors which could interfere with evaluation or completion of the study

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes